Free Trial

Spirit AeroSystems, Hess rise; Dynavax, TransUnion fall

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

Spirit AeroSystems Holdings Inc., up $1.80 to $39.94.

The Biden administration is providing $482 million to aviation industry manufacturers to help avert job or pay cuts in the pandemic.

Itamar Medical Ltd., up $9.61 to $30.25.

Zoll Medical is buying the medical device and digital health company for $538 million.

Regenxbio Inc., up $10.32 to $43.40.

The biotechnology company is collaborating with AbbVie on eye-condition treatments.

Dynavax Technologies Corp., down $2.81 to $14.74.

Britain canceled an order for 100 million doses of COVID-19 vaccine from the biotechnology company's partner Valneva.

TransUnion, down $2.52 to $120.71.

The credit reporting company is buying data services company Neustar for $3.1 billion.

Hess Corp. up $3.62 to $71.39.

Oil and gas prices rose and helped lift energy company stocks.

Dexcom Inc., down $8.95 to $540.43.

Chief operating officer Quentin Blackford is resigning.

Canadian Pacific Railway Ltd., up 1 cent to $68.55.

Kansas City Southern has accepted a $31 billion buyout bid from the railroad.

Should You Invest $1,000 in Kansas City Southern Right Now?

Before you consider Kansas City Southern, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kansas City Southern wasn't on the list.

While Kansas City Southern currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRankâ„¢Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
TransUnion (TRU)
4.6063 of 5 stars
$91.611.6%0.50%48.73Moderate Buy$109.69
Canadian Pacific Kansas City (CP)
1.1978 of 5 stars
C$109.95-0.3%0.69%29.03Moderate BuyC$120.00
Dynavax Technologies (DVAX)
4.3988 of 5 stars
$10.281.2%N/A-19.77Moderate Buy$24.00
Hess (HES)
4.8741 of 5 stars
$142.42-0.8%1.40%19.70Moderate Buy$162.86
DexCom (DXCM)
4.8963 of 5 stars
$82.73-1.0%N/A61.74Moderate Buy$98.50
REGENXBIO (RGNX)
4.5239 of 5 stars
$8.731.3%N/A-2.81Moderate Buy$31.63
Kansas City Southern (KSU)N/A$293.59flat0.74%287.84N/AN/A
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines